{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:20:14Z","timestamp":1792016414669,"version":"4.4.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s145630","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T17:34:46Z","timestamp":1564076086000},"page":"951-955","source":"Crossref","is-referenced-by-count":64,"title":["<p>Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives<\/p>"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"IE","family":"Overwater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-0836","authenticated-orcid":true,"given":"AB","family":"Rietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"van Eeghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MCY","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,7]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=51557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=51557","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T17:34:47Z","timestamp":1564076087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/everolimus-for-the-treatment-of-refractory-seizures-associated-with-tu-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s145630","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}